title: Endovascular treatment for acute ischemic stroke: experience in South Australia.
authors.affiliation: Stroke Research Programme, Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.
authors.forename: Laura Ivete
authors.initials: LI
authors.lastname: Rudaks
authors.affiliation: Radiology Department, Geelong Hospital, Geelong, Vic., Australia.
authors.forename: Idin
authors.initials: I
authors.lastname: Ahangar
authors.affiliation: Stroke Unit, The Queen Elizabeth Hospital, Woodville, SA, Australia.
authors.forename: Lizzie
authors.initials: L
authors.lastname: Dodd
authors.affiliation: Stroke Research Programme, The Queen Elizabeth Hospital, Woodville, SA, Australia.
authors.forename: Austin Graham
authors.initials: AG
authors.lastname: Milton
authors.affiliation: Stroke Research Programme, Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.|Stroke Research Programme, Neurology Department, The Queen Elizabeth Hospital, Woodville, SA, Australia.
authors.forename: Monica Anne
authors.initials: MA
authors.lastname: Hamilton-Bruce
authors.affiliation: Stroke Unit, The Queen Elizabeth Hospital, Woodville, SA, Australia.
authors.forename: Jim
authors.initials: J
authors.lastname: Jannes
authors.affiliation: Stroke Research Programme, Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.|Stroke Research Programme, Neurology Department, The Queen Elizabeth Hospital, Woodville, SA, Australia.
authors.forename: Simon Andrea
authors.initials: SA
authors.lastname: Koblar
mesh_terms: D000368:Aged; D002545:Brain Ischemia / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D057510:Endovascular Procedures / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D019635:Neurosurgical Procedures / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D012720:Severity of Illness Index; D013021:South Australia / Q000453:epidemiology; D015607:Stents; D020521:Stroke / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D062606:Tertiary Care Centers; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator